| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Saudi Arabia | 52 | 2021 | 4423 | 1.68 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 32 | 2021 | 8843 | 1.39 | Why? |
| Ubiquitin-Protein Ligase Complexes | 1 | 2018 | 2 | 0.77 | Why? |
| Spermatids | 1 | 2018 | 2 | 0.77 | Why? |
| Seminiferous Tubules | 1 | 2018 | 25 | 0.75 | Why? |
| Spermatogenesis | 1 | 2018 | 126 | 0.69 | Why? |
| Islam | 3 | 2020 | 545 | 0.67 | Why? |
| Gene Deletion | 1 | 2018 | 430 | 0.63 | Why? |
| Cross Infection | 13 | 2019 | 8675 | 0.51 | Why? |
| Infertility, Male | 1 | 2018 | 322 | 0.51 | Why? |
| Interferon beta-1b | 3 | 2020 | 274 | 0.49 | Why? |
| Respiratory Tract Infections | 8 | 2018 | 6817 | 0.46 | Why? |
| Dengue Virus | 1 | 2018 | 910 | 0.43 | Why? |
| Crowding | 4 | 2020 | 731 | 0.43 | Why? |
| Uridine Monophosphate | 2 | 2019 | 41 | 0.37 | Why? |
| Seasons | 2 | 2018 | 4071 | 0.36 | Why? |
| Meningitis, Bacterial | 1 | 2009 | 111 | 0.35 | Why? |
| Fluorenes | 2 | 2019 | 101 | 0.35 | Why? |
| Coronavirus Infections | 44 | 2021 | 253789 | 0.33 | Why? |
| Disease Outbreaks | 13 | 2019 | 27595 | 0.31 | Why? |
| Dengue | 1 | 2018 | 1565 | 0.30 | Why? |
| Coronavirus | 10 | 2016 | 18339 | 0.30 | Why? |
| Benzimidazoles | 2 | 2019 | 275 | 0.30 | Why? |
| Camelus | 6 | 2016 | 1425 | 0.29 | Why? |
| Hepatitis C, Chronic | 3 | 2019 | 973 | 0.28 | Why? |
| Sequence Deletion | 2 | 2019 | 674 | 0.26 | Why? |
| Aging | 1 | 2018 | 3581 | 0.23 | Why? |
| Religious Missions | 1 | 2020 | 11 | 0.23 | Why? |
| Adult | 44 | 2021 | 244371 | 0.22 | Why? |
| Complement C3a | 1 | 2021 | 73 | 0.22 | Why? |
| Ritonavir | 4 | 2020 | 4212 | 0.22 | Why? |
| Chemokine CCL5 | 1 | 2021 | 169 | 0.21 | Why? |
| Lopinavir | 3 | 2020 | 4308 | 0.21 | Why? |
| Complement C5a | 1 | 2021 | 116 | 0.21 | Why? |
| Hepacivirus | 3 | 2019 | 1509 | 0.20 | Why? |
| Leishmania major | 1 | 2019 | 9 | 0.20 | Why? |
| Leishmania tropica | 1 | 2019 | 10 | 0.20 | Why? |
| Nursing Staff, Hospital | 1 | 2013 | 1554 | 0.19 | Why? |
| Vibrio cholerae | 1 | 2019 | 44 | 0.19 | Why? |
| Leishmaniasis, Cutaneous | 1 | 2019 | 48 | 0.19 | Why? |
| Antiprotozoal Agents | 1 | 2019 | 83 | 0.19 | Why? |
| Male | 47 | 2021 | 367725 | 0.19 | Why? |
| Travel | 7 | 2021 | 7220 | 0.18 | Why? |
| Sperm Motility | 1 | 2018 | 106 | 0.18 | Why? |
| Middle Aged | 39 | 2021 | 270681 | 0.18 | Why? |
| Female | 48 | 2021 | 380317 | 0.18 | Why? |
| Influenza, Human | 4 | 2018 | 10779 | 0.17 | Why? |
| Vitamin D3 24-Hydroxylase | 1 | 2017 | 13 | 0.17 | Why? |
| Semantic Web | 1 | 2017 | 53 | 0.17 | Why? |
| Young Adult | 21 | 2021 | 93724 | 0.17 | Why? |
| Adolescent | 20 | 2021 | 86841 | 0.16 | Why? |
| Base Sequence | 5 | 2019 | 3581 | 0.16 | Why? |
| Mosquito Control | 1 | 2018 | 237 | 0.16 | Why? |
| Liver Cirrhosis | 2 | 2018 | 1810 | 0.16 | Why? |
| Aged | 31 | 2021 | 215776 | 0.15 | Why? |
| Sequence Analysis, DNA | 2 | 2016 | 2830 | 0.15 | Why? |
| Economic Development | 1 | 2018 | 167 | 0.15 | Why? |
| Humans | 69 | 2021 | 930598 | 0.15 | Why? |
| Cholera | 1 | 2019 | 189 | 0.15 | Why? |
| Mice, Knockout | 2 | 2018 | 1815 | 0.15 | Why? |
| Proto-Oncogene Proteins B-raf | 1 | 2017 | 179 | 0.15 | Why? |
| Mosquito Vectors | 1 | 2018 | 351 | 0.15 | Why? |
| Meningococcal Vaccines | 1 | 2018 | 225 | 0.15 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.15 | Why? |
| Interleukin-8 | 1 | 2021 | 964 | 0.15 | Why? |
| Genome, Bacterial | 1 | 2019 | 446 | 0.14 | Why? |
| Meningococcal Infections | 1 | 2018 | 216 | 0.14 | Why? |
| Sequence Homology | 1 | 2016 | 448 | 0.14 | Why? |
| Serum | 1 | 2016 | 294 | 0.14 | Why? |
| beta-Thalassemia | 1 | 2017 | 200 | 0.14 | Why? |
| Middle East | 3 | 2014 | 1418 | 0.14 | Why? |
| Antibodies, Viral | 5 | 2021 | 51949 | 0.13 | Why? |
| Housing | 2 | 2019 | 1146 | 0.13 | Why? |
| Carcinoma | 1 | 2017 | 256 | 0.13 | Why? |
| Chemoprevention | 1 | 2018 | 585 | 0.13 | Why? |
| Catheter-Related Infections | 1 | 2017 | 381 | 0.13 | Why? |
| Phylogeny | 7 | 2019 | 13341 | 0.13 | Why? |
| Respiratory System | 3 | 2015 | 3213 | 0.13 | Why? |
| Glucocorticoids | 1 | 2009 | 4431 | 0.13 | Why? |
| Cluster Analysis | 3 | 2016 | 3001 | 0.12 | Why? |
| Serogroup | 1 | 2015 | 510 | 0.12 | Why? |
| Pharmacovigilance | 1 | 2017 | 501 | 0.12 | Why? |
| Communicable Diseases, Imported | 1 | 2020 | 843 | 0.12 | Why? |
| Sustained Virologic Response | 3 | 2019 | 378 | 0.12 | Why? |
| Hospitals, General | 1 | 2017 | 711 | 0.12 | Why? |
| Aged, 80 and over | 14 | 2021 | 88759 | 0.11 | Why? |
| Thyroid Neoplasms | 1 | 2017 | 422 | 0.11 | Why? |
| Sulfonamides | 2 | 2018 | 1294 | 0.11 | Why? |
| Acute Disease | 2 | 2018 | 6029 | 0.11 | Why? |
| Microbiota | 1 | 2021 | 1240 | 0.11 | Why? |
| Anemia, Sickle Cell | 1 | 2017 | 546 | 0.11 | Why? |
| Molecular Epidemiology | 1 | 2016 | 1638 | 0.10 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 2 | 2019 | 1316 | 0.10 | Why? |
| Pregnancy Complications, Infectious | 1 | 2016 | 11559 | 0.10 | Why? |
| Family Characteristics | 2 | 2018 | 2551 | 0.10 | Why? |
| Nasal Mucosa | 2 | 2015 | 1218 | 0.10 | Why? |
| Influenza A Virus, H1N1 Subtype | 3 | 2013 | 2984 | 0.10 | Why? |
| Drug Interactions | 1 | 2017 | 1653 | 0.10 | Why? |
| Pneumonia, Ventilator-Associated | 1 | 2017 | 861 | 0.10 | Why? |
| Risk Factors | 9 | 2021 | 71621 | 0.09 | Why? |
| Genome, Viral | 4 | 2016 | 13157 | 0.09 | Why? |
| Age Factors | 4 | 2020 | 21039 | 0.09 | Why? |
| Influenza Vaccines | 2 | 2018 | 2941 | 0.09 | Why? |
| Health Personnel | 8 | 2021 | 29646 | 0.09 | Why? |
| Antiviral Agents | 5 | 2020 | 41703 | 0.09 | Why? |
| Indoles | 1 | 2017 | 1243 | 0.09 | Why? |
| Malaria | 1 | 2018 | 1097 | 0.09 | Why? |
| Virus Shedding | 2 | 2015 | 5834 | 0.09 | Why? |
| Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.09 | Why? |
| Disease Transmission, Infectious | 3 | 2018 | 9044 | 0.09 | Why? |
| Family Health | 1 | 2013 | 731 | 0.09 | Why? |
| Blood Donors | 1 | 2021 | 2956 | 0.08 | Why? |
| Child | 10 | 2021 | 70012 | 0.08 | Why? |
| Health Education | 1 | 2018 | 1539 | 0.08 | Why? |
| Advisory Committees | 1 | 2014 | 1418 | 0.08 | Why? |
| Genomics | 1 | 2019 | 3118 | 0.08 | Why? |
| Picornaviridae Infections | 1 | 2011 | 544 | 0.08 | Why? |
| Aspartate Aminotransferases | 1 | 2013 | 1394 | 0.08 | Why? |
| Environmental Exposure | 1 | 2016 | 1558 | 0.08 | Why? |
| Animals | 12 | 2021 | 78931 | 0.08 | Why? |
| Infectious Disease Incubation Period | 1 | 2013 | 1033 | 0.07 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.07 | Why? |
| Carrier State | 2 | 2015 | 2100 | 0.07 | Why? |
| Drug Combinations | 3 | 2020 | 3852 | 0.07 | Why? |
| L-Lactate Dehydrogenase | 1 | 2013 | 1995 | 0.07 | Why? |
| Mass Screening | 3 | 2021 | 8005 | 0.07 | Why? |
| Drug Therapy, Combination | 4 | 2020 | 7268 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.07 | Why? |
| Nasopharynx | 2 | 2014 | 10224 | 0.07 | Why? |
| Double-Blind Method | 3 | 2020 | 5988 | 0.07 | Why? |
| Population Surveillance | 3 | 2017 | 4967 | 0.07 | Why? |
| Sofosbuvir | 2 | 2019 | 518 | 0.06 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.06 | Why? |
| Evolution, Molecular | 2 | 2014 | 3691 | 0.06 | Why? |
| Religion | 2 | 2018 | 353 | 0.06 | Why? |
| Pregnancy Outcome | 1 | 2016 | 3803 | 0.06 | Why? |
| DNA, Viral | 1 | 2013 | 2521 | 0.06 | Why? |
| Genotype | 3 | 2019 | 4697 | 0.06 | Why? |
| Child, Preschool | 8 | 2021 | 36283 | 0.06 | Why? |
| RNA, Viral | 5 | 2019 | 32276 | 0.06 | Why? |
| Intensive Care Units | 3 | 2020 | 29594 | 0.06 | Why? |
| Type C Phospholipases | 1 | 2001 | 6 | 0.06 | Why? |
| Genetic Variation | 1 | 2016 | 3919 | 0.06 | Why? |
| Arginine Vasopressin | 1 | 2001 | 14 | 0.06 | Why? |
| Caco-2 Cells | 2 | 2016 | 1236 | 0.06 | Why? |
| Antibody Formation | 1 | 2015 | 4038 | 0.06 | Why? |
| Host-Pathogen Interactions | 2 | 2020 | 11041 | 0.06 | Why? |
| Lypressin | 1 | 2001 | 9 | 0.06 | Why? |
| Multicenter Studies as Topic | 2 | 2020 | 2437 | 0.06 | Why? |
| Odds Ratio | 1 | 2013 | 5861 | 0.06 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.06 | Why? |
| Mice | 2 | 2018 | 21357 | 0.06 | Why? |
| Dinoprost | 1 | 2001 | 49 | 0.06 | Why? |
| Tertiary Care Centers | 2 | 2016 | 8248 | 0.05 | Why? |
| Diarrhea | 1 | 2013 | 2743 | 0.05 | Why? |
| Bacterial Infections | 1 | 2015 | 2229 | 0.05 | Why? |
| Endometrium | 1 | 2001 | 68 | 0.05 | Why? |
| Communicable Disease Control | 2 | 2020 | 29620 | 0.05 | Why? |
| Ribavirin | 2 | 2018 | 1182 | 0.05 | Why? |
| Retrognathia | 1 | 2020 | 17 | 0.05 | Why? |
| Community-Acquired Infections | 1 | 2013 | 2328 | 0.05 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 4 | 2019 | 9706 | 0.05 | Why? |
| Sex Ratio | 1 | 2021 | 69 | 0.05 | Why? |
| History, 21st Century | 2 | 2019 | 1849 | 0.05 | Why? |
| Ceremonial Behavior | 1 | 2020 | 63 | 0.05 | Why? |
| Prevalence | 5 | 2017 | 25773 | 0.05 | Why? |
| Thrombocytopenia | 1 | 2013 | 2093 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 3 | 2020 | 10649 | 0.05 | Why? |
| Fever | 2 | 2014 | 7795 | 0.05 | Why? |
| Hospitals | 1 | 2019 | 11793 | 0.05 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.05 | Why? |
| Vaccination | 3 | 2021 | 19050 | 0.05 | Why? |
| Coinfection | 1 | 2019 | 6820 | 0.05 | Why? |
| Premarital Examinations | 1 | 2017 | 2 | 0.05 | Why? |
| 2-Naphthylamine | 1 | 2018 | 54 | 0.05 | Why? |
| Yemen | 1 | 2019 | 136 | 0.05 | Why? |
| Molecular Sequence Data | 2 | 2014 | 3198 | 0.05 | Why? |
| Injections, Subcutaneous | 1 | 2020 | 647 | 0.05 | Why? |
| Unified Medical Language System | 1 | 2017 | 2 | 0.04 | Why? |
| Macrocyclic Compounds | 1 | 2018 | 78 | 0.04 | Why? |
| Virus Replication | 1 | 2019 | 14331 | 0.04 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.04 | Why? |
| Uracil | 1 | 2018 | 101 | 0.04 | Why? |
| Lactams, Macrocyclic | 1 | 2018 | 130 | 0.04 | Why? |
| Pharmacokinetics | 1 | 2017 | 41 | 0.04 | Why? |
| Infection Control | 5 | 2021 | 23131 | 0.04 | Why? |
| Viral Load | 2 | 2019 | 15850 | 0.04 | Why? |
| Anilides | 1 | 2018 | 105 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
| Pharmacology | 1 | 2017 | 27 | 0.04 | Why? |
| Travel Medicine | 1 | 2020 | 335 | 0.04 | Why? |
| Sex Factors | 3 | 2021 | 11014 | 0.04 | Why? |
| Virus Diseases | 1 | 2015 | 3779 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2020 | 1008 | 0.04 | Why? |
| Whole Genome Sequencing | 2 | 2019 | 3239 | 0.04 | Why? |
| Air Conditioning | 1 | 2019 | 215 | 0.04 | Why? |
| 5' Untranslated Regions | 1 | 2019 | 375 | 0.04 | Why? |
| Nasal Septum | 1 | 2016 | 44 | 0.04 | Why? |
| Knowledge Bases | 1 | 2017 | 113 | 0.04 | Why? |
| Comorbidity | 5 | 2020 | 34796 | 0.04 | Why? |
| Carcinoma, Papillary | 1 | 2017 | 76 | 0.04 | Why? |
| Mice, Nude | 1 | 2017 | 340 | 0.04 | Why? |
| Valine | 1 | 2018 | 359 | 0.04 | Why? |
| Renal Dialysis | 1 | 2013 | 4358 | 0.04 | Why? |
| Coronary Care Units | 1 | 2017 | 224 | 0.04 | Why? |
| Proline | 1 | 2018 | 345 | 0.04 | Why? |
| Calcium | 1 | 2001 | 708 | 0.04 | Why? |
| Betacoronavirus | 1 | 2020 | 204454 | 0.04 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2016 | 37182 | 0.04 | Why? |
| Cyclopropanes | 1 | 2018 | 332 | 0.04 | Why? |
| Cross-Sectional Studies | 6 | 2021 | 53120 | 0.04 | Why? |
| Pharmacogenetics | 1 | 2017 | 222 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 8811 | 0.04 | Why? |
| Data Interpretation, Statistical | 1 | 2020 | 657 | 0.04 | Why? |
| Sequence Homology, Nucleic Acid | 1 | 2016 | 368 | 0.04 | Why? |
| Treatment Outcome | 5 | 2020 | 51732 | 0.04 | Why? |
| Abattoirs | 1 | 2015 | 94 | 0.04 | Why? |
| Genetic Counseling | 1 | 2017 | 229 | 0.04 | Why? |
| Blood | 1 | 2015 | 274 | 0.03 | Why? |
| Animal Husbandry | 1 | 2015 | 162 | 0.03 | Why? |
| Cohort Studies | 4 | 2019 | 36005 | 0.03 | Why? |
| Carbamates | 1 | 2018 | 485 | 0.03 | Why? |
| Gene Amplification | 1 | 2013 | 85 | 0.03 | Why? |
| Pregnancy | 1 | 2016 | 23879 | 0.03 | Why? |
| World Health Organization | 2 | 2019 | 4213 | 0.03 | Why? |
| Kenya | 1 | 2016 | 887 | 0.03 | Why? |
| Genes, Viral | 1 | 2019 | 1428 | 0.03 | Why? |
| Up-Regulation | 1 | 2021 | 2249 | 0.03 | Why? |
| Administration, Oral | 1 | 2020 | 2340 | 0.03 | Why? |
| Urine | 1 | 2015 | 469 | 0.03 | Why? |
| Emigration and Immigration | 1 | 2018 | 501 | 0.03 | Why? |
| Catheterization, Central Venous | 1 | 2017 | 458 | 0.03 | Why? |
| Infant | 3 | 2021 | 30274 | 0.03 | Why? |
| Open Reading Frames | 1 | 2019 | 1898 | 0.03 | Why? |
| Cell Line | 2 | 2019 | 12040 | 0.03 | Why? |
| Lung | 1 | 2021 | 31049 | 0.03 | Why? |
| Endemic Diseases | 1 | 2016 | 480 | 0.03 | Why? |
| Swine | 1 | 2001 | 3352 | 0.03 | Why? |
| Contact Tracing | 3 | 2019 | 8448 | 0.03 | Why? |
| Urinary Tract Infections | 1 | 2017 | 534 | 0.03 | Why? |
| Virus Cultivation | 1 | 2015 | 579 | 0.03 | Why? |
| Fluorescent Antibody Technique | 1 | 2014 | 835 | 0.03 | Why? |
| Masks | 1 | 2013 | 8528 | 0.03 | Why? |
| Holidays | 1 | 2014 | 311 | 0.03 | Why? |
| Kaplan-Meier Estimate | 1 | 2020 | 4260 | 0.03 | Why? |
| Selection, Genetic | 1 | 2014 | 691 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2017 | 2739 | 0.02 | Why? |
| Occupations | 1 | 2015 | 733 | 0.02 | Why? |
| Vero Cells | 2 | 2016 | 14117 | 0.02 | Why? |
| Syndrome | 1 | 2013 | 1310 | 0.02 | Why? |
| Mycobacterium tuberculosis | 1 | 2017 | 1164 | 0.02 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.02 | Why? |
| Protective Clothing | 1 | 2011 | 468 | 0.02 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2016 | 3608 | 0.02 | Why? |
| Prospective Studies | 3 | 2019 | 43301 | 0.02 | Why? |
| Prognosis | 2 | 2021 | 32490 | 0.02 | Why? |
| Protein Kinase Inhibitors | 1 | 2017 | 1585 | 0.02 | Why? |
| Demography | 1 | 2014 | 1660 | 0.02 | Why? |
| Pharynx | 1 | 2014 | 1544 | 0.02 | Why? |
| Bacteremia | 1 | 2017 | 1372 | 0.02 | Why? |
| Laboratories | 1 | 2019 | 2858 | 0.02 | Why? |
| Republic of Korea | 1 | 2019 | 5858 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2017 | 5814 | 0.02 | Why? |
| Rhinovirus | 1 | 2011 | 979 | 0.02 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2019 | 3129 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 13720 | 0.02 | Why? |
| Cells, Cultured | 1 | 2016 | 5835 | 0.02 | Why? |
| Symptom Assessment | 1 | 2019 | 4967 | 0.02 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 11367 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Disease Reservoirs | 1 | 2014 | 1672 | 0.02 | Why? |
| Fatal Outcome | 1 | 2014 | 3438 | 0.02 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.02 | Why? |
| Universities | 1 | 2019 | 4374 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.02 | Why? |
| Heart Diseases | 1 | 2020 | 3503 | 0.02 | Why? |
| HIV Infections | 1 | 2009 | 11620 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 3633 | 0.01 | Why? |
| Basic Reproduction Number | 1 | 2014 | 2676 | 0.01 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
| Feces | 1 | 2015 | 4235 | 0.01 | Why? |
| Asymptomatic Diseases | 1 | 2014 | 3444 | 0.01 | Why? |
| Patient Compliance | 1 | 2011 | 1468 | 0.01 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2014 | 3607 | 0.01 | Why? |
| Epidemiological Monitoring | 1 | 2014 | 3493 | 0.01 | Why? |
| Patient Admission | 1 | 2018 | 5250 | 0.01 | Why? |
| Guideline Adherence | 1 | 2014 | 2309 | 0.01 | Why? |
| Stromal Cells | 1 | 2001 | 105 | 0.01 | Why? |
| Oxytocin | 1 | 2001 | 76 | 0.01 | Why? |
| Cough | 1 | 2014 | 4891 | 0.01 | Why? |
| Antibodies, Neutralizing | 2 | 2019 | 25288 | 0.01 | Why? |
| Family | 1 | 2014 | 2909 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2014 | 6740 | 0.01 | Why? |
| Registries | 1 | 2018 | 12327 | 0.01 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.01 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2011 | 43792 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Respiratory Insufficiency | 1 | 2014 | 7301 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2016 | 22116 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Epithelial Cells | 1 | 2001 | 3508 | 0.01 | Why? |